HLscience Statistics
Total Valuation
HLscience has a market cap or net worth of KRW 59.94 billion. The enterprise value is 33.61 billion.
Market Cap | 59.94B |
Enterprise Value | 33.61B |
Important Dates
The last earnings date was Tuesday, March 18, 2025.
Earnings Date | Mar 18, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
HLscience has 5.09 million shares outstanding. The number of shares has decreased by -0.04% in one year.
Current Share Class | n/a |
Shares Outstanding | 5.09M |
Shares Change (YoY) | -0.04% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 66.98% |
Owned by Institutions (%) | n/a |
Float | 1.68M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 3.39 |
PB Ratio | 0.63 |
P/TBV Ratio | 0.64 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -4.27 |
EV / Sales | 1.90 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -7.10 |
Financial Position
The company has a current ratio of 16.68, with a Debt / Equity ratio of 0.00.
Current Ratio | 16.68 |
Quick Ratio | 14.46 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | -0.10 |
Interest Coverage | -665.04 |
Financial Efficiency
Return on equity (ROE) is -8.08% and return on invested capital (ROIC) is -6.23%.
Return on Equity (ROE) | -8.08% |
Return on Assets (ROA) | -6.05% |
Return on Invested Capital (ROIC) | -6.23% |
Return on Capital Employed (ROCE) | -10.29% |
Revenue Per Employee | 245.34M |
Profits Per Employee | -109.40M |
Employee Count | 72 |
Asset Turnover | 0.17 |
Inventory Turnover | 2.30 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.95% in the last 52 weeks. The beta is 1.01, so HLscience's price volatility has been similar to the market average.
Beta (5Y) | 1.01 |
52-Week Price Change | -24.95% |
50-Day Moving Average | 11,575.60 |
200-Day Moving Average | 13,208.55 |
Relative Strength Index (RSI) | 58.54 |
Average Volume (20 Days) | 12,089 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HLscience had revenue of KRW 17.66 billion and -7.88 billion in losses. Loss per share was -1,547.00.
Revenue | 17.66B |
Gross Profit | 7.29B |
Operating Income | -9.86B |
Pretax Income | -8.29B |
Net Income | -7.88B |
EBITDA | -7.30B |
EBIT | -9.86B |
Loss Per Share | -1,547.00 |
Balance Sheet
The company has 26.87 billion in cash and 450.00 million in debt, giving a net cash position of 26.42 billion or 5,187.14 per share.
Cash & Cash Equivalents | 26.87B |
Total Debt | 450.00M |
Net Cash | 26.42B |
Net Cash Per Share | 5,187.14 |
Equity (Book Value) | 94.63B |
Book Value Per Share | 18,563.75 |
Working Capital | 31.20B |
Cash Flow
In the last 12 months, operating cash flow was -3.59 billion and capital expenditures -1.14 billion, giving a free cash flow of -4.73 billion.
Operating Cash Flow | -3.59B |
Capital Expenditures | -1.14B |
Free Cash Flow | -4.73B |
FCF Per Share | -929.54 |
Margins
Gross margin is 41.25%, with operating and profit margins of -55.82% and -44.59%.
Gross Margin | 41.25% |
Operating Margin | -55.82% |
Pretax Margin | -46.93% |
Profit Margin | -44.59% |
EBITDA Margin | -41.33% |
EBIT Margin | -55.82% |
FCF Margin | n/a |
Dividends & Yields
HLscience does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.04% |
Shareholder Yield | 0.04% |
Earnings Yield | -13.14% |
FCF Yield | -7.90% |
Stock Splits
The last stock split was on December 29, 2020. It was a forward split with a ratio of 1.05.
Last Split Date | Dec 29, 2020 |
Split Type | Forward |
Split Ratio | 1.05 |
Scores
HLscience has an Altman Z-Score of 15.12.
Altman Z-Score | 15.12 |
Piotroski F-Score | n/a |